ML Randi, E Ruzzon, G Luzzatto, F Tezza, A Girolami, F Fabris. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. Haematologica 2005; 90(2):261-262.